We are live on ! Find out more
RGC

Roberts, Glore & Co Portfolio holdings

AUM $364M
1-Year Est. Return 19.54%
This Fund
S&P 500
This Quarter Est. Return
-0.74%
1 Year Est. Return
+19.54%
3 Year Est. Return
+59.43%
5 Year Est. Return
+77.93%
10 Year Est. Return
+273.65%
AUM
$329M
AUM Growth
-$5.18M
Cap. Flow
-$1.43M
Cap. Flow %
-0.44%
Top 10 Hldgs %
34.34%
Holding
206
New
10
Increased
48
Reduced
89
Closed
14

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$1.1M
2
T icon
AT&T
T
+$784K
3
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$633K
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$629K
5
AI icon
C3.ai
AI
+$591K

Top Sells

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$791K
2
ALXN
Alexion Pharmaceuticals
ALXN
+$679K
3
EFA icon
iShares MSCI EAFE ETF
EFA
+$666K
4
VBR icon
Vanguard Morningstar Small-Cap Value ETF
VBR
+$658K
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$395K

Sector Composition

Rank Sector Weight
1 Healthcare 20.89%
2 Technology 16.24%
3 Financials 10.88%
4 Industrials 9.41%
5 Communication Services 7.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CBOE icon
176
Cboe Global Markets
CBOE
$32.5B
$230K 0.07%
1,858
– –
QQQ icon
177
Invesco QQQ Trust
QQQ
$453B
$226K 0.07%
+631
New +$232K
ADI icon
178
Analog Devices
ADI
$179B
$223K 0.07%
+1,331
New +$223K
IWD icon
179
iShares Russell 1000 Value ETF
IWD
$82.2B
$222K 0.07%
1,417
– –
DEO icon
180
Diageo
DEO
$49B
$221K 0.07%
1,145
– –
SCHD icon
181
Schwab US Dividend Equity ETF
SCHD
$103B
$219K 0.07%
8,835
– –
ELV icon
182
Elevance Health
ELV
$81.5B
$214K 0.07%
575
-20
-3% -$7.6K
EVLV icon
183
Evolv Technologies
EVLV
$995M
$211K 0.06%
+35,200
New +$279K
EMF
184
Templeton Emerging Markets Fund
EMF
$317M
$210K 0.06%
12,350
– –
SAMG icon
185
Silvercrest Asset Management
SAMG
$79M
$210K 0.06%
13,449
– –
BBL
186
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
$210K 0.06%
4,150
– –
SMG icon
187
ScottsMiracle-Gro
SMG
$3.82B
$206K 0.06%
1,410
– –
MORN icon
188
Morningstar
MORN
$7.22B
$205K 0.06%
790
– –
WY icon
189
Weyerhaeuser
WY
$18B
$203K 0.06%
5,720
-200
-3% -$7.01K
BA icon
190
Boeing
BA
$171B
$202K 0.06%
919
– –
PEO
191
Adams Natural Resources Fund
PEO
$739M
$183K 0.06%
12,146
– –
ABEV icon
192
Ambev
ABEV
$48.1B
$82K 0.02%
29,880
-3,000
-9% -$9.5K
BIDU icon
193
Baidu
BIDU
$37.7B
– –
-3,879
Closed -$791K
CSX icon
194
CSX Corp
CSX
$93.4B
– –
-6,342
Closed -$203K
EFA icon
195
iShares MSCI EAFE ETF
EFA
$78B
– –
-8,440
Closed -$666K
GPN icon
196
Global Payments
GPN
$23B
– –
-1,260
Closed -$236K
JD icon
197
JD.com
JD
$44.6B
– –
-3,275
Closed -$261K
KTF
198
DWS Municipal Income Trust
KTF
$346M
– –
-10,149
Closed -$124K
MA icon
199
Mastercard
MA
$506B
– –
-571
Closed -$208K
RYN icon
200
Rayonier
RYN
$6.55B
– –
-6,443
Closed -$210K
5 6 7
8
9

Similar funds

VBFP
Valtinson Bruner Financial Planning New Brighton, Minnesota $364M AUM 9.63% 1-Year Est. Return
EW
Evexia Wealth Stevens Point, Wisconsin $364M AUM 29.61% 1-Year Est. Return
RBFC
Roman Butler Fullerton & Co St Louis, Missouri $364M AUM 27.64% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
DCP
Davern Capital Partners Ny, New York $365M AUM
MA
Modus Advisors Excelsior, Minnesota $363M AUM 22.99% 1-Year Est. Return
SWA
Strata Wealth Advisors Dallas, Texas $365M AUM 16.8% 1-Year Est. Return
OAJ
Ogorek Anthony Joseph Williamsville, New York $365M AUM 18.21% 1-Year Est. Return

Roberts, Glore & Co's Q3 2021 Portfolio in Review

As of Q3 2021, Roberts, Glore & Co held 206 positions worth $329M, down 1.5% from $334M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Roberts, Glore & Co's Q3 2021 filing shows 10 new, 48 increased, 89 reduced and 14 closed positions. Its largest new stake was Vertex Pharmaceuticals: 5,655 shares worth $1.03M. The largest sale was Baidu, an estimated $791K.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 21% a quarter earlier, followed by Technology and Financials.

  • Roberts, Glore & Co's largest Q3 2021 buy was Vertex Pharmaceuticals: 5,655 shares worth $1.03M.
  • Roberts, Glore & Co added most to State Street SPDR S&P MIDCAP 400 ETF Trust in Q3 2021, an estimated $633K increase.
  • Roberts, Glore & Co's biggest Q3 2021 reduction was Vanguard Morningstar Small-Cap Value ETF, cutting an estimated $658K.
  • Roberts, Glore & Co fully exited Baidu in Q3 2021, selling an estimated $791K.
  • Roberts, Glore & Co's ten largest holdings make up 34% of its $329M portfolio in Q3 2021.
  • Roberts, Glore & Co opened 10 new positions and closed 14 in Q3 2021.
  • Roberts, Glore & Co's portfolio value fell 1.5% quarter-over-quarter to $329M.

Based on Roberts, Glore & Co's 13F filing for Q3 2021, filed 12 Nov 2021.